Anthem Capital Management
VC Fund
Baltimore, United States
Anthem Capital Management is an early stage venture firm that invests in companies in the mid-Atlantic states. Anthem’s team has accumulated more than 50 years of venture capital experience. They were early venture investors in such companies as Apple Computer, Samna (Lotus’s word processor), Sequoia Software, HealthSouth, Phycor, CorporateChildcare Services, Immunicon and Sensors for Medicine and Sciences. Regional FootprintAnthem invests exclusively in the Mid-Atlantic states and serves this area from offices located in three of the region’s key markets: the Baltimore–Washington corridor, the Greater Philadelphia market, and the Greater Pittsburgh market.Industry FocusAnthem seeks opportunities in IT/telecom and healthcare/life sciences industries. IT investments are most frequently made in enterprise software or network management software companies. Medical investments tend to fall into three categories: medical devices, biotechnology or healthcare.Investment StageAnthem invests in early to expansion stage opportunities. Typically, our initial investment is made in the Series A or Series B institutional venture capital round. We have led or co-led 80% of the investments we have made, but also will participate in syndicates where appropriate.Investment SizeAnthem seeks to invest between $2 million and $4 million in a company from the first private equity round through exit. Typically, our initial investment ranges from $1 million to $2 million
- Total investments:
- 12
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Anthem Capital Management invests in
Stages Anthem Capital Management invests in
Countries Anthem Capital Management invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Xander Perry
|
|||
Bill Gust
|
|||
Ed Spiva
|
|||
Gerry Schaafsma
|
|||
Investment Focus
Industry
- Software 3 (25%)
- Mobile 2 (17%)
- Internet 2 (17%)
- Health Care 2 (17%)
- Enterprise Software 2 (17%)
Stage
- Series B 5 (42%)
- Series A 3 (25%)
- Funding Round 2 (17%)
- Series C 1 (8%)
- Series E 1 (8%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Xander Perry
Partner
|
Partner | Total investments: 4 | Find email | |
|
Bill Gust
Partner
|
Partner | Total investments: 0 | Find email | |
|
Ed Spiva
Partner
|
Partner | Total investments: 0 | Find email | |
|
Gerry Schaafsma
Partner
|
Partner | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
GlycoMimetics
|
GlycoMimetics, Inc., a biopharmaceutical company, engages in the design and development of small molecule therapeutics to mimic the functions of bioactive carbohydrates. Its products include GMI-1070, a synthetic glycomimetic molecule designed to inhibit selectin types, such as E, P, and L-selectin; and GMI-1051, a small molecular weight compoundfor the treatment or prevention of infections caused by pseudomonas aeruginosa. The company was founded in 2003 and is based in Gaithersburg, Maryland. | $38M / Series C / Dec 07, 2009 | |
Siperian
|
Siperian helps companies unify critical data about customers, products and organizations that is fragmented across systems to deliver reliable, complete views of this data within existing business processes. With unified views of key business entity data, companies can benefit from information assets within operating and analytical businessprocesses.Siperian MDM Hub™ offers the next generation of architectural flexibility for managing all master data with an integrated, model-driven software platform that adapts to your business requirements-- and delivers rapid return on investment in critical MDM projects today while evolving to a complete enterprise MDM platform. Siperian's approach enables rapid implementation and has earned the company its reputation for leadership and proven success.Siperian solutions meet the complex requirements of market-leading companies in financial services, health and life sciences, manufacturing and technology, information services and media and other industry sectors improve customer relationship management and analytical processes, along with regulatory compliance, order-to-cash and new product launch processes—at faster time-to-value and higher return on investment compared to alternatives.The company markets and supports its leading MDM solutions through its own sales, professional services and support organizations in concert with its partner program network of systems integrators and technology providers. Their partners include, among others, Accenture, HP, CSC, BearingPoint, IBM, Identity Systems, Salesforce.com, Harte Hanks Trillium Software, Business Objects, Cognos and Experian.Pfizer, Deutsche Bank, Forest Laboratories, Allergan, State Street Bank, EcoLab, EMC Corporation and LexisNexis are among the Fortune 500 companies that trust Siperian solutions. With proven deployments, these satisfied customers operate large-scale master data management solutions addressing customer, location and product data to support both analytical and transactional business needs. | $25M / Series E / Jan 22, 2008 | |
Defywire
|
Defywire, Inc. develops wireless connections between teachers, administrators, students, and parents. The company offers Mobile Guardian, a web-based administration console that allows centralized management of mobile users, applications, and school configuration information. Its Mobile Guardian provides access to critical information, reconnectingthrough cellular, wireless fidelity, satellite, LAN or WAN, or other communication protocols, as well as supports blackberry and various Windows mobile devices, XP desktops, notebooks, and tablet PC's. The company was founded in 2003 and is based in Reston, Virginia. | $7M / Mar 27, 2007 | |
|
GlycoMimetics
|
GlycoMimetics, Inc., a biopharmaceutical company, engages in the design and development of small molecule therapeutics to mimic the functions of bioactive carbohydrates. Its products include GMI-1070, a synthetic glycomimetic molecule designed to inhibit selectin types, such as E, P, and L-selectin; and GMI-1051, a small molecular weight compoundfor the treatment or prevention of infections caused by pseudomonas aeruginosa. The company was founded in 2003 and is based in Gaithersburg, Maryland. | $15.4M / Series B / Jun 23, 2006 | |
Triumfant
|
Triumfant provides continuous protection from advanced malware threats on the endpoint, stopping cybercriminals in their tracks. Offering the most advanced detection capabilities and featuring enhanced memory and Mac features, Triumfant ensures that once inside a company’s or government agency’s systems, no attacker can leave with proprietaryinformation, damage to enterprise systems is minimized, and critical assets are secured. Triumfant stops a breach before it becomes a full-scale attack then automatically repairs the machine(s) and any collateral damage within minutes – no human intervention or system downtime is required. When attacks occur, companies and government entities trust Triumfant to quickly recover and prevent loss. | $6M / Series B / Mar 02, 2006 | |
|
Defywire
|
Defywire, Inc. develops wireless connections between teachers, administrators, students, and parents. The company offers Mobile Guardian, a web-based administration console that allows centralized management of mobile users, applications, and school configuration information. Its Mobile Guardian provides access to critical information, reconnectingthrough cellular, wireless fidelity, satellite, LAN or WAN, or other communication protocols, as well as supports blackberry and various Windows mobile devices, XP desktops, notebooks, and tablet PC's. The company was founded in 2003 and is based in Reston, Virginia. | $3.6M / Series B / Apr 26, 2005 | |
|
GlycoMimetics
|
GlycoMimetics, Inc., a biopharmaceutical company, engages in the design and development of small molecule therapeutics to mimic the functions of bioactive carbohydrates. Its products include GMI-1070, a synthetic glycomimetic molecule designed to inhibit selectin types, such as E, P, and L-selectin; and GMI-1051, a small molecular weight compoundfor the treatment or prevention of infections caused by pseudomonas aeruginosa. The company was founded in 2003 and is based in Gaithersburg, Maryland. | $5.1M / Series A / Aug 06, 2004 | |
Qovia
|
Qovia provides voice over Internet protocol telephony monitoring and management technologies and products. It develops software products to monitor and manage voice quality on Internet telephone systems. The company's customers include school districts, government agencies, law enforcement agencies, banking and financial institutions, callcenters, and voice carriers. Qovia, Inc. was founded in 2002 and is based in Frederick, Maryland. | $10.6M / Series B / Apr 19, 2004 | |
|
Qovia
|
Qovia provides voice over Internet protocol telephony monitoring and management technologies and products. It develops software products to monitor and manage voice quality on Internet telephone systems. The company's customers include school districts, government agencies, law enforcement agencies, banking and financial institutions, callcenters, and voice carriers. Qovia, Inc. was founded in 2002 and is based in Frederick, Maryland. | $5.5M / Series A / Oct 21, 2003 | |
|
Defywire
|
Defywire, Inc. develops wireless connections between teachers, administrators, students, and parents. The company offers Mobile Guardian, a web-based administration console that allows centralized management of mobile users, applications, and school configuration information. Its Mobile Guardian provides access to critical information, reconnectingthrough cellular, wireless fidelity, satellite, LAN or WAN, or other communication protocols, as well as supports blackberry and various Windows mobile devices, XP desktops, notebooks, and tablet PC's. The company was founded in 2003 and is based in Reston, Virginia. | $4.5M / Series A / Jun 04, 2003 | |
| See all 12 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Anthem Capital Management invest in?
Anthem Capital Management invests primarily in Software, Mobile and Internet startups, most often at Series B and Series A stage. Most of the 12 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Anthem Capital Management?
Public channels for Anthem Capital Management include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Anthem Capital Management?
The team at Anthem Capital Management includes Xander Perry (Partner), Bill Gust (Partner) and Ed Spiva (Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
